麻豆传媒

Focus: Coronavirus Channel Featured Story 2

Filters close
12-Dec-2023 3:05 PM EST
鈥楲ong flu鈥 has emerged as a consequence similar to long COVID
Washington University in St. Louis

New research from Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care System comparing the viruses that cause the flu and COVID-19 shows that people hospitalized with seasonal influenza also can suffer long-term, negative health effects, especially involving their lungs and airways. The study also found that in the 18 months after infection, patients hospitalized for either COVID-19 or seasonal influenza faced an increased risk of death, hospital readmission, and other health problems.

7-Feb-2023 9:00 AM EST
Tobacco and e-cigs may put healthy young people at risk of severe COVID illness, new UCLA research suggests
University of California, Los Angeles (UCLA), Health Sciences

Smoking tobacco and vaping electronic cigarettes may increase healthy young people鈥檚 risk for developing severe COVID illness.

麻豆传媒: Alcoholic Pancreatitis Patients with Continued Alcohol Intake May Finally Have Therapeutic Options
Released: 21-Oct-2022 2:50 PM EDT
Alcoholic Pancreatitis Patients with Continued Alcohol Intake May Finally Have Therapeutic Options
University of Miami Health System, Miller School of Medicine

Researchers at the Miller School are looking for solutions to the continued effects of alcohol use, its harmful impact, and treatment. Understanding the mechanisms of alcohol abuse has gained importance, especially after the COVID-19 pandemic. Higher alcohol consumption led to an increased burden of pancreatic diseases in society.

麻豆传媒: Needs and Challenges for COVID-19 Boosters and Other Vaccines in the U.S.
Released: 18-Oct-2022 8:30 AM EDT
Needs and Challenges for COVID-19 Boosters and Other Vaccines in the U.S.
Florida Atlantic University

FAU researchers and collaborators provide the most updated guidance to health care providers and urge how widespread vaccination with these boosters can now avoid the specter of future and more lethal variants becoming a reality.

Released: 19-Sep-2022 4:50 PM EDT
Facemask can detect viral exposure from a 10-minute conversation with an infected person
Cell Press

Scientists have created a face mask that can detect common respiratory viruses, including influenza and the coronavirus, in the air in droplets or aerosols.

   
Released: 18-May-2022 5:00 PM EDT
COVID Booster Needed for Broad Protection Against Omicron Variants
Ohio State University

A COVID-19 booster shot will provide strong and broad antibody protection against the range of omicron sublineage variants of the SARS-CoV-2 virus in circulation, two new studies using serum from human blood samples suggest.

麻豆传媒: Scientists Use Machine Learning Models to Help Identify Long COVID Patients
Released: 17-May-2022 2:10 PM EDT
Scientists Use Machine Learning Models to Help Identify Long COVID Patients
University of North Carolina School of Medicine

Clinical scientists used machine learning models to explore de-identified electronic health record data in the National COVID Cohort Collaborative (N3C) to help discern characteristics of people with long COVID and factors that may help identify such patients using data from medical records.

麻豆传媒: Chemical Found in Leafy Greens Shown to Slow Growth of COVID-19 and Common Cold Viruses
Released: 23-Mar-2022 12:45 PM EDT
Chemical Found in Leafy Greens Shown to Slow Growth of COVID-19 and Common Cold Viruses
Johns Hopkins Medicine

Researchers at Johns Hopkins Children鈥檚 Center report evidence from lab experiments that a chemical derived from a compound found abundantly in broccoli and other cruciferous plants may offer a potentially new and potent weapon against the viruses that cause COVID-19 and the common cold.

Released: 17-Mar-2022 12:20 PM EDT
Memory and concentration problems are common in long COVID and must not be ignored, say scientists
University of Cambridge

Around 70% of long COVID patients in a new study experienced difficulty concentrating and memory problems several months after infection with the virus SARS-CoV-2.

Released: 10-Mar-2022 4:15 PM EST
Antivirals, some antibodies, work well against BA.2 omicron variant of COVID-19 virus
University of Wisconsin鈥揗adison

The antiviral therapies remdesivir, molnupiravir, and the active ingredient in Pfizer鈥檚 Paxlovid pill (nirmatrelvir), remain effective in laboratory tests against the BA.2 variant of SARS-CoV-2, the virus that causes COVID-19. The BA.2 variant also remains susceptible to at least some of the monoclonal antibodies used to treat COVID-19, such as Evusheld by AstraZeneca.

麻豆传媒: Did COVID-19 Make Tinnitus, 鈥楻inging鈥 in the Ears, Worse?
Released: 2-Mar-2022 8:30 AM EST
Did COVID-19 Make Tinnitus, 鈥楻inging鈥 in the Ears, Worse?
Florida Atlantic University

Many people impacted by COVID-19 experienced changes in their sense of smell, taste, hearing, balance and in some cases, tinnitus, 鈥渞inging鈥 in the ears. Among the various causes of tinnitus is stress. What鈥檚 unclear, however, is whether the psychological impacts of the pandemic such as stress actually worsened tinnitus. Results of a new study do not support the idea that the pandemic led to a worsening of tinnitus.

麻豆传媒: Metabolism of COVID-19 Antibodies from Convalescent Plasma Suggests Possible Safe Treatment for High Risk Children
Released: 7-Feb-2022 12:05 PM EST
Metabolism of COVID-19 Antibodies from Convalescent Plasma Suggests Possible Safe Treatment for High Risk Children
Johns Hopkins Medicine

Johns Hopkins Medicine researchers report that a prospective study of 14 infants and children demonstrated that convalescent plasma 鈥 a blood product collected from patients recovered from infections with the coronavirus (SARS-CoV-2) that causes COVID-19鈥 was safe in high risk children infected with or exposed to the virus.

Released: 7-Feb-2022 11:05 AM EST
COVID-19 infections increase risk of heart conditions up to a year later
Washington University in St. Louis

An analysis of federal health data indicates that people who have had COVID-19 are at increased risk of developing cardiovascular complications within the first month to a year after infection, according to researchers at Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care System.

麻豆传媒: 鈥楽he Was No Longer My Sister鈥 鈥 University of Kentucky Neurologists Help Patient Suffering from COVID-Induced Psychosis
Released: 27-Jan-2022 2:35 PM EST
鈥楽he Was No Longer My Sister鈥 鈥 University of Kentucky Neurologists Help Patient Suffering from COVID-Induced Psychosis
University of Kentucky

Aleina and Kelly Milligan are more than sisters - they are truly best friends. For Kelly, her older sister has been a lifeline during the past two years. As Kelly settled in with her sister in Columbia, Kentucky, Aleina became concerned when she noticed a change in Kelly鈥檚 seizure patterns. The sisters then made the trip to Lexington for an appointment with UK HealthCare鈥檚 Sally Mathias, M.D., assistant professor of Neurology, who specializes in epilepsy.

Released: 12-Jan-2022 12:40 PM EST
How to Protect Yourself During the Omicron COVID-19 Surge: How to Go Out Safely
RUSH

Michael Lin, MD, MPH, an infectious disease specialist, explains how risky some activities are now as the highly transmissible omicron variant surges through Chicago and the rest of the country.

麻豆传媒: Do you need a COVID-19 booster shot?
Released: 16-Nov-2021 9:00 AM EST
Do you need a COVID-19 booster shot?
University of Georgia

If you got the COVID-19 shots back in early spring, your antibodies are likely waning. But it鈥檚 not something you need to be worried about, according to a new study from the University of Georgia.

5-Nov-2021 4:15 PM EDT
COVID-19: The older you are, the more antibodies you have
Universite de Montreal

Universit茅 de Montr茅al chemists looked at lab samples of patients who recovered from a mild case of COVID-19 and found that those over 50 produced more antibodies against the SARS-CoV-2 virus.

Released: 1-Nov-2021 2:00 PM EDT
In Covid-19 Vaccinated People, Those with Prior Infection Likely to Have More Antibodies
Johns Hopkins Medicine

In what is believed to be one of the largest studies of its kind, Johns Hopkins Medicine researchers have shown that antibody levels against SARS-CoV-2 (the COVID-19 virus) stay more durable 鈥 that is, remain higher over an extended period of time 鈥 in people who were infected by the virus and then received protection from two doses of messenger RNA (mRNA) vaccine compared with those who only got immunized.



close
1.91633